
AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site
WILMINGTON, DE — AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals …
AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site Read More